Gold Royalty to Release Second Quarter 2026 Results on August 5, 2026 and Announces Acquisition of Additional Royalties

Gold Royalty Corp. (NYSE American: GROY) said it will release Q2 2026 results after market close on Aug. 5, 2026, with a conference call on Aug. 6. It also announced it acquired two Nevada NSR royalties from a private seller for US$0.8 million, including a 2.0% NSR on Sterling and a 0.5% NSR on Granite Creek.

Original reporting
Published Jul 13, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$GROY
Neutral
medium confidence
Mentioned
$GROY
Relevance
6/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$GROYNeutralMed
01

Why it matters

The actionable items are the fixed earnings timing and the disclosed acquisition terms (2.0% NSR on Sterling, 0.5% NSR on Granite Creek with $31,500/year advance minimums).

02

Market read

Provides a concrete earnings calendar catalyst and a disclosed, incremental portfolio expansion that may influence expectations ahead of the Aug 5 after-close results.

03

What to watch

Traders may focus on whether the acquired NSR royalties come with meaningful advance minimum royalty payments and how they affect realized margins, but the article does not quantify expected contribution beyond the $31,500/year minimum for Granite Creek.

Relevance 6/10Novelty 6/10Timing: After-hours Aug 5, 2026 Q2 results release, followed by Aug 6 conference call.

Background

Gold Royalty is a gold-focused royalty and streaming company; this release schedules its Q2 2026 results and announces a small Nevada NSR royalty acquisition.

Company-level read

Ticker impact

$GROYNeutralMedium confidence
Context

Gold Royalty will release Q2 2026 results after the close Aug 5, 2026, and it also acquired two Nevada NSR royalties for $0.8M.

Expected impact

Likely modest, with most price action around the Aug 5 after-close results and any commentary on royalty performance and future acquisition pace.

Evidence & confidence

The article provides a concrete event date (Aug 5 after close) and a disclosed acquisition size ($0.8M) but no earnings numbers, guidance, or material contract terms beyond royalty percentages and locations.

Market effects

Adds incremental evidence of continued portfolio-building by a gold royalty/streaming model, but scale is small so sector read-through is limited.

Nevada royalty exposure may be a minor positive for regional gold development sentiment, given the Sterling and Granite Creek assets.

Limited global impact; primarily company-specific timing and portfolio expansion.

Counterpoint

The $0.8M acquisition is small, so it may not materially change near-term cash flows; the stock reaction could be dominated by Q2 results rather than the deal.

Key entities

  • Gold Royalty Corp.

    NYSE American-listed gold royalty and streaming company releasing Q2 2026 results Aug 5, 2026 and acquiring additional Nevada NSR royalties.

  • Sterling property (Nevada)

    Operated by AngloGold Ashanti Limited; subject to a 2.0% NSR royalty acquired by Gold Royalty.

  • Granite Creek (Nevada)

    Operated by i-80 Gold Corp.; subject to a 0.5% NSR royalty with associated advance minimum royalty payments of $31,500 per year.

Related articles

$GROYMed

What Gold Royalty (GROY) Said on Its Q3 Earnings Call

Gold Royalty (GROY) expects 28,000-34,000 GEOs production by 2030. REN project to reach 140,000 oz/year by late 2027, with payments starting in early 2028. Vareš mine restarted, expected to be a major revenue contributor in 2027. The company has $21M in cash, no debt, and a $125M credit facility. It is considering a capital return policy and plans to announce preliminary Q4 revenue in mid-February.

$GROYMed

Gold Royalty (GROY) Q3 2026 Earnings Call Transcript

Gold Royalty (GROY) reported record Q3 2026 results, with adjusted revenue of $11.5M and 2,689 GEOs produced. The company expects to meet or exceed full-year production guidance of 7,500-9,300 GEOs. Gold Royalty's royalty model provides leverage to rising gold prices and lower risk compared to other gold investments. The company is considering returning capital to shareholders and has a strong balance sheet with $21M in cash and no debt.

$GROYMed

Gold Royalty Corp. (GROY): Financial results for 9M 2026

Gold Royalty Corp. (GROY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 GOLD ROYALTY REPORTS RECORD THREE AND NINE-MONTH RESULTS WITH CONTINUED STRONG CASH FLOW AND EARNINGS GROWTH Vancouver, British Columbia – November 4, 2026 – Gold Royalty Corp. (“ Gold Royalty ” or the “ Company ”) (NYSE American: GROY) is pleased to announce the fil

$GROYMed

Gold Royalty Q2 Earnings Call Highlights

Gold Royalty Corp (GROY) discussed its Q2 earnings call, saying its NSR royalty model is based on revenue and can be insulated from mine operating cost inflation. It maintained 2026 guidance of 7,500 to 9,300 GEOs, with 1H at 44% of the midpoint. It also outlined ramp-up and acquisition updates, including a $6.25M REN NSR add-on and new Nevada royalties.

$GROYHigh

Gold Royalty Corp. (GROY): Financial results for H1 2026

Gold Royalty Corp. (GROY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Gold Royalty Reports record SIX-MONTH results with continued strong cash flow and EARNINGS growth Vancouver, British Columbia – August 5, 2026 – Gold Royalty Corp. (“ Gold Royalty ” or the “ Company ”) (NYSE American: GROY) is pleased to announce the filing of its op

$AVRMedAI 8/10

Anteris Reports Strong One-Year Results For DurAVR Heart Valve In High-Risk Aortic Stenosis Patients

Anteris Technologies (AVR) reported one-year data for its DurAVR heart valve, showing strong performance in high-risk aortic stenosis patients. Key metrics include 1% hospitalization for heart failure, 8.9 mmHg mean pressure gradient, and 96% of patients with mild or no symptoms post-treatment. The study involved 100 patients with complex conditions. Anteris stock closed at $4.99, up to $5.09 in after-hours trading.